UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

AMENDMENT NO. 1
FORM 10-Q/A

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2000

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission file number 0-22890

SANGSTAT MEDICAL CORPORATION
(Exact name of Registrant as specified in its charter)

 

Delaware	94-3076-069
(State or Other Jurisdiction of Incorporation or Organization)	(IRS Employer Identification Number)

6300 Dumbarton Circle
Fremont, California   94555
(Address of principal executive offices)

510-789-4300
(Registrant's telephone number, including area code)

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days.    YES [X]    NO [  ]

    Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

 

CLASS	NUMBER OF SHARES
Common Stock	18,046,851

	The following items were the subject of a Form 12b-25 and are included herein: Item 6 of Part II and Exhibit 10.34.

EXPLANATORY NOTE

This Amendment to Form 10-Q is filed for the purpose of filing Exhibit 10.34 and amending and restating in its entirety Part II, Item 6.

1. EXHIBITS - The following exhibits are attached hereto and filed herewith:

Exhibit Number	Description of Document
10.34	Co-Development, Supply and License Agreement1
27.1	Financial Data Schedule2

________________

¹The Company has applied for confidential treatment with respect to portions of this exhibit.

²Previously filed as an exhibit to the Company's Form 10-Q filed November 14, 2000.




2. (b) We filed Current Reports on Form 8-K on July 14, 2000, July 21, 2000, August 2, 2000, and August 30, 2000.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused This report to be signed on its behalf by the undersigned thereunto duly authorized.

	SangStat Medical Corporation

	(Registrant)

Dated: November 17, 2000

	By:	/s/ STEPHEN G. DANCE

	Stephen G. Dance
	Senior Vice President, Finance
	(Principal Financial Officer)